The team at Sullivan & Worcester LLP is experienced at assisting companies, from start-up to profitability to public company, notably advising venture capital firms in the software, telecommunications, therapeutics, and fintech industries. New York’s Scott Kaufman co-heads the group and regularly acts for entrepreneurs, technology and life science companies, and investors in venture financings, M&A, and corporate transactions. Meanwhile, Lewis Segall heads the corporate department in Boston, providing support to start-ups and investors on equity and debt financings, joint ventures, and M&A. Also in Boston, Benjamin Armour heads the mergers & acquisitions group at the firm and works closely with clients on growth strategies, liquidity events, and investment of capital.
Legal 500 Editorial commentary
Key clients
- 97212 Studio/97212 Management
- Agilitas Energy
- AIwithCare Inc.
- Alarum Technologies Ltd.
- Alliance Global Partners
- BiomX Inc.
- Biomica Ltd.
- Concorde Health
- Datanon Corporation
- ICONYC Labs
- Inso Biosciences, Inc.
- IPR.VC Management
- Jefferson Capital Partners
- KUDO
- Money in Motion
- Olibra
- Opanga Networks, Inc.
- Parley Neurotech Inc.
- PolyPid Ltd.
- Quicksilver Biosystems
Work highlights
Advising Arbol in connection with its capital raises, corporate acquisitions, employment issues, and various commodities laws and other regulatory issues, working with Arbol on credit facilities, reinsurance funds and other hedging structures to support the weather derivatives activities.
Represent Jefferson Capital Partners, a New Orleans-based private equity firm, in connection with forming multiple Opportunity Zone funds and investing in several regional portfolio companies.
Advising Truliant Consulting and its affiliates in connection with their sale to PrivateEquity-backed Eliquent Life Sciences, Inc.
Practice head
Scott Kaufman; Lewis Segall
Other key lawyers
Benjamin Armour